Barclays PLC Abbott Laboratories Put Options Transaction History

Barclays PLC

$377 Billion
Q3 2024

Put Options

22 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 15, 2024	BUY	$100.07 - $118.13 $2.55 Million - $3.01 Million	25,500 New	25,500 $2.91 Million
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $4.21 Million - $4.64 Million	38,400 Added 400.0%	48,000 $5.46 Million
Q4 2023 Feb 15, 2024	SELL	$90.19 - $110.4 $3.52 Million - $4.31 Million	-39,000 Reduced 80.25%	9,600 $1.06 Million
Q3 2023 Nov 07, 2023	SELL	$95.53 - $114.62 $15.2 Million - $18.2 Million	-159,000 Reduced 76.59%	48,600 $4.71 Million
Q2 2023 Aug 03, 2023	BUY	$100.78 - $112.29 $15.1 Million - $16.9 Million	150,200 Added 261.67%	207,600 $22.6 Million
Q1 2023 May 04, 2023	SELL	$96.86 - $114.01 $11.1 Million - $13.1 Million	-114,600 Reduced 66.63%	57,400 $5.81 Million
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $7.95 Million - $9.32 Million	83,600 Added 94.57%	172,000 $18.9 Million
Q3 2022 Nov 03, 2022	BUY	$96.76 - $112.03 $8.55 Million - $9.9 Million	88,400 New	88,400 $8.55 Million
Q4 2020 Feb 11, 2021	BUY	$105.0 - $114.42 $4.2 Million - $4.58 Million	40,000 Added 124.61%	72,100 $7.89 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $13.7 Million - $16.7 Million	-150,000 Reduced 82.37%	32,100 $3.49 Million
Q2 2020 Aug 12, 2020	SELL	$76.57 - $98.0 $5.61 Million - $7.18 Million	-73,300 Reduced 28.7%	182,100 $16.6 Million
Q1 2020 May 13, 2020	BUY	$62.82 - $91.86 $251,280 - $367,440	4,000 Added 1.59%	255,400 $20.2 Million
Q4 2019 Feb 10, 2020	BUY	$78.51 - $87.4 $10.9 Million - $12.1 Million	138,400 Added 122.48%	251,400 $21.8 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $1.26 Million - $1.37 Million	-15,400 Reduced 11.99%	113,000 $9.46 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $1.68 Million - $1.96 Million	-23,000 Reduced 15.19%	128,400 $10.8 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $562,870 - $680,510	-8,500 Reduced 5.32%	151,400 $12.1 Million
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $5.45 Million - $6.18 Million	-83,200 Reduced 34.22%	159,900 $11.6 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $6.17 Million - $7.44 Million	101,400 Added 71.56%	243,100 $17.8 Million
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $3.94 Million - $4.35 Million	68,400 Added 93.32%	141,700 $8.64 Million
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $9.89 Million - $11.2 Million	-175,800 Reduced 70.57%	73,300 $4.39 Million
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $1.38 Million - $1.48 Million	-25,700 Reduced 9.35%	249,100 $14.2 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $13.2 Million - $14.7 Million	274,800	274,800 $14.7 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.2 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$8.76 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.51 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.09 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account